Inflammation plays a critical role in prostate carcinogenesis, as evidenced by chronic inflammatory states and environmental factors contributing to prostate cancer development. The article discusses how exposure to infectious agents, dietary carcinogens, and hormonal imbalances can lead to chronic inflammation and regenerative 'risk factor' lesions, known as proliferative inflammatory atrophy (PIA). These lesions are associated with increased risk of prostate cancer, as shown by epidemiological, histopathological, and molecular studies. Prostate cancer is the most common non-cutaneous malignant neoplasm in men in Western countries, with incidence increasing as the population of men over 50 grows. The disease is not intrinsic to aging, as men in Southeast Asian countries have low incidence rates that increase after immigration to the West. The pathogenesis of prostate cancer involves both hereditary and environmental factors, with chronic inflammation being a key contributor. Inflammation is crucial for the aetiology of prostate cancer, as evidenced by the presence of inflammatory cells in prostate lesions and the association of chronic inflammation with increased cancer risk. The article reviews the role of PIA in prostate cancer development, highlighting the genetic and epigenetic changes associated with these lesions. It also discusses the role of infectious agents, such as bacteria and viruses, in prostate inflammation and cancer. Urine reflux and chemical trauma can also contribute to chronic inflammation in the prostate. Dietary factors, such as red meat and animal fats, are linked to increased prostate cancer risk, possibly through the formation of heterocyclic amines. Oestrogens are also implicated in prostate inflammation and cancer, as they can affect prostate growth and development. The article explores the immunobiology of prostate inflammation, highlighting the presence of inflammatory cells in prostate tissues and the role of T-cell responses in prostate cancer. It also discusses the role of inflammatory genes, such as RNASEL and MSR1, in prostate cancer risk. Toll-like receptors and other inflammatory-related genes are also discussed, with their association with prostate cancer risk. The article concludes that inflammation is a complex process involving many genes and that further research is needed to understand the mechanisms of prostate carcinogenesis and to develop strategies for prevention.Inflammation plays a critical role in prostate carcinogenesis, as evidenced by chronic inflammatory states and environmental factors contributing to prostate cancer development. The article discusses how exposure to infectious agents, dietary carcinogens, and hormonal imbalances can lead to chronic inflammation and regenerative 'risk factor' lesions, known as proliferative inflammatory atrophy (PIA). These lesions are associated with increased risk of prostate cancer, as shown by epidemiological, histopathological, and molecular studies. Prostate cancer is the most common non-cutaneous malignant neoplasm in men in Western countries, with incidence increasing as the population of men over 50 grows. The disease is not intrinsic to aging, as men in Southeast Asian countries have low incidence rates that increase after immigration to the West. The pathogenesis of prostate cancer involves both hereditary and environmental factors, with chronic inflammation being a key contributor. Inflammation is crucial for the aetiology of prostate cancer, as evidenced by the presence of inflammatory cells in prostate lesions and the association of chronic inflammation with increased cancer risk. The article reviews the role of PIA in prostate cancer development, highlighting the genetic and epigenetic changes associated with these lesions. It also discusses the role of infectious agents, such as bacteria and viruses, in prostate inflammation and cancer. Urine reflux and chemical trauma can also contribute to chronic inflammation in the prostate. Dietary factors, such as red meat and animal fats, are linked to increased prostate cancer risk, possibly through the formation of heterocyclic amines. Oestrogens are also implicated in prostate inflammation and cancer, as they can affect prostate growth and development. The article explores the immunobiology of prostate inflammation, highlighting the presence of inflammatory cells in prostate tissues and the role of T-cell responses in prostate cancer. It also discusses the role of inflammatory genes, such as RNASEL and MSR1, in prostate cancer risk. Toll-like receptors and other inflammatory-related genes are also discussed, with their association with prostate cancer risk. The article concludes that inflammation is a complex process involving many genes and that further research is needed to understand the mechanisms of prostate carcinogenesis and to develop strategies for prevention.